{
    "type": "VariantTherapeuticResponseProposition",
    "predicate": "sensitivity",
    "description": "Treatment of pediatric patients 1 year of age and older with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) in combination with chemotherapy",
    "geneContextQualifier": "BCR | ABL1",
    "objectTherapeutic": "Dasatinib [Sprycel]"
}